3/20
09:58 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at Guggenheim.
3/20
09:58 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at Guggenheim.
3/20
09:45 am
imvt
Rating for IMVT
Medium
Report
Rating for IMVT
3/20
09:45 am
imvt
Rating for IMVT
Medium
Report
Rating for IMVT
3/19
12:38 pm
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
Low
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
3/10
12:19 pm
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at Guggenheim.
Low
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at Guggenheim.
3/10
12:19 pm
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at Guggenheim.
Low
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at Guggenheim.
3/10
12:08 pm
imvt
Rating for IMVT
Low
Report
Rating for IMVT
3/10
12:08 pm
imvt
Rating for IMVT
Low
Report
Rating for IMVT
3/5
07:43 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Low
Report
Immunovant, Inc. (NASDAQ: IMVT) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
3/2
12:06 pm
imvt
Immunovant initiated with a Hold at Jefferies
High
Report
Immunovant initiated with a Hold at Jefferies
3/2
12:06 pm
imvt
Immunovant initiated with a Hold at Jefferies
High
Report
Immunovant initiated with a Hold at Jefferies
2/10
08:35 am
imvt
Rating for IMVT
Medium
Report
Rating for IMVT
2/10
08:35 am
imvt
Rating for IMVT
Medium
Report
Rating for IMVT
2/7
03:56 pm
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
Low
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
2/1
05:58 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Medium
Report
Immunovant, Inc. (NASDAQ: IMVT) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.